To train and compare machine-learning algorithms with traditional regression analysis for the prediction of early biochemical recurrence after robot-assisted prostatectomy.
Introduction
In the era of electronic medical records in medicine, large amounts of data have been collected and are readily available for evaluation; however, these datasets require appropriate analyses and interpretation to make clinically meaningful changes in patient outcomes.
Machine learning is the semi-automated extraction of knowledge and insight from data. Developed within the fields of statistics, computer science and artificial intelligence, it allows the training of algorithms that can discover and identify complex patterns and relationships faster than conventional statistical models that focus on only a handful of patient variables. In medicine, developed algorithms can be directly applied to patient care to improve the accuracy of predicting diseases and subsequent outcomes.
Prostate cancer is the most common non-skin cancer and the second leading cause of death from cancer in men in the USA. It is a highly prevalent and heterogeneous disease with several treatment pathways and various patient trajectories. After radical prostatectomy for localized prostate cancer, the rate of biochemical recurrence with an elevated PSA at a median time of 2 years approaches 15% [1] . The median time from biochemical recurrence after radical prostatectomy to the development of metastases is 8 years, and the median time from metastases to death is 5 years [1] ; thus, early prediction of biochemical recurrence is important for guiding treatment pathways and patient prognosis.
Predictive algorithms have the potential to identify high-risk patients for whom close observation and early intervention can affect disease trajectory and decrease healthcare costs [2] . As the comparison of machine-learning algorithms in the field of urology is relatively scarce, we sought to compare and evaluate the utility of multiple supervised machine-learning techniques to predict early biochemical recurrence after robot-asssisted prostatectomy. In the present paper, we compare our models with conventional Cox regression models to evaluate whether there were improvements in the predictive ability from using modern machine-learning techniques.
Patients and Methods

Study Population and Model Variables
Patient data were derived from a prospectively collected database of consecutive men with prostate cancer who underwent robot-assisted laparoscopic prostatectomy between May 2012 and December 2015 at St Joseph's Hospital by a single surgeon (B.S.). Demographic information, clinical assessments, laboratory results, radiographic findings, biopsy features, operative details, pathological features and postoperative outcomes were prospectively collected (Table 1) . Early biochemical recurrence was defined as per the AUA guidelines as a postoperative PSA concentration > 0.2 ng/mL at 1 year follow-up [3] .
Machine-learning Models
Three machine-learning algorithms were used to build predictive models: K-nearest neighbour, random forest classifier and logistic regression. The K-nearest neighbour algorithm is one of the simplest machine-learning models. The principle of K-nearest neighbour is to find a predefined number of training data features (known as K) with known labels closest to the new data point and subsequently predict the new label based on the K-nearest training points. For example, if K = 1, the single known label closest to the new data point will be the label of the new data point. If K = 3, the three closest data points are collected and the most common label of the three will be the label of the new data point. K-nearest neighbour is a non-generalizing machinelearning method as it simply 'remembers' all of the training data and selects the data labels closest to the new point. Despite its simplicity, K-nearest neighbour is useful in a large number of classification and regression problems and is often successful in classification situations where the decision boundaries are irregular. Because of this, K-nearest neighbour is highly sensitive to the local data environments compared with the overall dataset.
Random forest is a 'tree-based' algorithm whereby multiple decision trees are built using a random assortment of independent variables that are used to predict an outcome data label. Using a 'majority vote' system, a new sample is predicted by the multiple decision trees in the random forest model, and the ultimate classification of this new sample is based on the classification predicted by the majority of the decision trees.
Logistic regression is one of the most popular machinelearning algorithms for binary classification. It utilizes the logistic function which is an S-shaped curve that can take any real number and map it into a value between 0 and 1, but never actually reaches those limits. Quick to train and resistant to data overfitting, logistic regression makes no assumptions about the structure of data and is easily extended to multiple classifications.
The aim of creating our models was to predict which patients would develop early biochemical recurrence based on the variables listed in Table 1 . Our machine-learning algorithms were trained and tested using Scikit-learn version 0.17.1 (Scikit-learn, Gif-sur-Yvette, France) and Python version 3.6.2 (Python, Beaverton, OR, USA) as the programming language [4] . In building our machine-learning algorithms, we used a 'hypothesis-free' approach, without selection bias, to identify variables included in our models and included any variable for which the majority of patients had a data value; that is, we did not include variables based on any a priori hypotheses of their ability to predict outcome. We included patients with complete data across all variables and then randomly split them into a 70% training set and a 30% test set. There are no standardized ratios for separating data into training and test sets; however, the 70/30 proportion is commonly used in machine learning for complex models. For model training, data from the training set were used to approximate model parameters. We used 10-fold cross-validation for training our model to decrease risk of model overfitting, and no modifications were made to the machine-learning models based on performance in validation. Each model's ability to discriminate between early biochemical recurrence outcomes (defined as PSA < 0.2 ng/mL = 0, PSA > 0.2 ng/mL = 1) was determined using accuracy scores, sensitivity, specificity and the area under the receiver-operating characteristic curve metric based on model performance on the test set.
Model Comparison
To compare whether our models provided better predictive accuracy than standard statistical methodology, we performed a conventional Cox proportional hazards regression model analysis for predicting biochemical recurrence using IBM SPSS â Statistics version 20 (IBM, Armonk, NY, USA). In the patient training set, we used univariate analysis to identify which variables were significantly associated with biochemical recurrence using a chi-squared test for categorical variables and analysis of variance for continuous variables. Using variables with a P value < 0.1, the model was then applied to the test patient set and the area under the curve (AUC) was calculated and compared with our machine-learning algorithms.
Results
Patient Characteristics
The characteristics of patients included in our predictive models are described In Table 2 . We used 19 different variables from demographics, clinical assessments and operative data. A total of 338 patients had complete data across these domains and were included in our prediction models. For the model, this included 25 patients with our outcome (early biochemical recurrence or PSA > 0.2 ng/mL at 1 year) and 313 controls (no evidence of biochemical recurrence).
Univariate Analysis
Univariate Cox regression analysis performed on our cohort showed that ASA (hazard ratio (Table 3) .
Machine-learning Models
We built predictive models (K-nearest neighbour [K = 55], random forest tree, logistic regression) to identify patients who would develop early biochemical recurrence after radical prostatectomy. A total of 19 patient variables were used to create the machine-learning algorithms. Each of their predictive performances is shown in Table 4 . Accuracy prediction scores for K-nearest neighbour, random forest tree and logistic regression were 0.976, 0.953 and 0.976, respectively, and the AUCs for receiver-operating characteristic curves (Fig. 1) for K-nearest neighbour, random forest tree and logistic regression were 0.903, 0.924 and 0.940, respectively. We also used a classic Cox regression model (AUC 0.865), including statistically significant variables associated with biochemical recurrence (above), which was better than PSA alone (AUC 0.686) for the prediction of biochemical recurrence (Fig. 2) . All three of our machinelearning models outperformed the conventional statistical regression model in the prediction of biochemical recurrence after prostatectomy.
Discussion
We have described the use of three different machinelearning algorithms to create predictive models to identify patients with early biochemical recurrence at 1 year after robot-assisted prostatectomy. Statistical methods have conventionally been used for this purpose, despite the complex interactions of high-dimensional medical data. Our predictive models, trained in a hypothesis-free fashion, were generated from a variety of patient data including clinical, imaging and operative variables. The ability of machinelearning tools to use complex datasets highlights their potential ability to accurately predict outcomes.
Important cancer control endpoints after radical prostatectomy are pathologically organ-confined disease with clear surgical margins, biochemical recurrence, local progression, metastases, cancer-specific survival and overall survival. Biochemical recurrence is usually the earliest evidence of tumour recurrence after radical prostatectomy [1] . Biochemical recurrence is frequently used as an intermediate endpoint for treatment outcomes; however, not all patients with biochemical recurrence ultimately develop metastases or die from prostate cancer. Biochemical recurrence usually precedes prostate cancer metastases by a mean of 8 years and cancer-specific mortality by 13 years [1] . Previously defined independent clinical prognostic factors are tumour stage, Gleason grade, preoperative PSA level, and prostate cancer treatment. Other previously reported prognostic features include non-organ-confined disease, lymphovascular invasion, extracapsular extension, positive surgical margins, seminal vesicle invasion and lymph node metastases [5, 6] .
Each of the machine-learning models used in the present study, K-nearest neighbour (AUC 0.903), random forest classifier (AUC 0.924) and logistic regression (AUC 0.940), outperformed classic Cox regression analysis (AUC 0.865) for the prediction of early biochemical recurrence. Each of the models is described in detail in the methods section (above). These models can provide meaningful risk estimates for the classification task at hand. With accurate predictive models, physicians and patients alike can be provided with a more reliable estimate of the probability of outcome and appropriate risk stratification.
Machine learning has been previously used for predictive outcomes in other fields of medicine including the identification of peripheral artery disease and future mortality risk [7] . Ross et al. evaluated patient data from the Genetic Determinants of Peripheral Arterial Disease study of 1047 patients using 130 different patient variables. Using the random forest tree algorithm, the authors showed that their machine-learning models were markedly better calibrated than conventional statistical modelling.
Within the field of urology, machine learning has also been used in the prediction of mortality after radical cystectomy for bladder cancer [8] . Wang et al. [8] used a data set of 117 patients who underwent radical cystectomy for bladder cancer to predict the 5-year mortality after radical cystectomy using seven machine-learning models, including back-propagation neural network, radial basis function, extreme learning machine, regularized extreme learning machine, support Recently, machine learning has been used to process automated performance metrics to evaluate surgical performance and predict clinical outcomes after robot-assisted radical prostatectomy [9] . In that study, random forest algorithm, support vector machines and logistic regression were investigated to exhibit the most accurate algorithm by comparing the outputs with the actual values as the ground truth. They were trained using automated performance metrics from the robot and the patients' length of hospital stay. The metrics included instrument travel time, path length, velocity, frequency of clutching, camera movements, third arm and energy usage. The authors showed that random forest-50 had the best performance, with an accuracy of 87.2%. Furthermore, they showed that patient outcomes that were predicted by the model included surgery time, length of hospital stay and urethral catheter duration.
In the present study, the models were generated from information captured from a relatively small prospective database with currently limited follow-up from a singlesurgeon cohort. Further follow-up is required, particularly with the analysis of prostate cancer because the hazard of prostate cancer-specific recurrence continues to increase for at least 15 years after radical prostatectomy, and the risks of mortality may increase for 25 years or more [10, 11] , therefore, continuous follow-up and monitoring of these patients are required [12] . An additional challenge with machine learning is the fact that the performance of the models on new data cannot be predicted before testing, which may not identify overfitting in new datasets. Our models performed similarly on the training and test sets suggesting that overfitting was not an issue within our data. With increasing amounts of test data available, this potential limitation would be minimized. Furthermore, we used only patients who had complete data to build our models. In clinical practice, patient data are frequently missing, which may reduce predictive accuracy. Such methods limit use for real-world data, balancing the limitations of different imputation techniques.
We are, however, entering an era in which complete patient data are becoming more readily available. We will soon be able to apply predictive analytics to larger datasets, which should generate clinically meaningful insights into and accurately predict patient outcomes across a broad range of conditions. For example, machine-learning algorithms can be designed to continuously surveil the electronic medical record in a rapid and automated fashion, providing real-time up-todate predictive analytics for patient care. Using newer analytical approaches, these models will not be static and will one day learn to better predict an individual's clinical trajectory over time. Once a model has been developed by the algorithm, no additional computational cost would be required to predict biochemical recurrence and additional time during the clinical interview to integrate into practice should not be required. Furthermore, such models can be 'retrained' locally at different institutions to maximize accuracy in different populations of patients with different clinical and demographic profiles. Perhaps the true value of machine learning is in its ability to continuously self-learn and evolve with the ongoing addition of endless data. Ultimately, machine learning may enable the automated detection of individuals with biochemical recurrence of prostate cancer and allow individualized monitoring and interventions before the development of metastatic disease.
Our machine-learning algorithms had better predictive capabilities compared with classic regression models for the prediction of early biochemical recurrence after radical prostatectomy. Such methodology can be employed as potentially more accurate and automated ways of identifying at-risk patients for conditions for which good risk prediction methods do not exist or are found to have relatively poor performance.
The benefits of machine learning in this setting and in the future will be to arm patients and physicians with prognostic information and provide personalized healthcare. Algorithms can be tailored to preoperative factors or postoperative factors to not only predict biochemical recurrence but other postoperative factors including urinary incontinence or 
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© 2018 The Authors BJU International © 2018 BJU International erectile dysfunction. Furthermore, using preoperative patient factors, perhaps with further data from a cohort of men who underwent radiation therapy, the prediction of biochemical recurrence could be compared and patients could be armed with further information to guide them towards a patientcentred treatment pathway. Future studies should attempt to test and validate local models, with the aim of reducing the prevalence of undiagnosed disease and the burden of adverse clinical outcomes related to delays in preventive interventions.
